MedTrace Logo

Smartphone Confocal Microscopy for Diagnosing Kaposi's Sarcoma

NCT03050788 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 363

Last updated 2020-10-26

No results posted yet for this study

Summary

The investigators propose to evaluate a novel diagnostic approach for Kaposi's sarcoma (KS) that may be eventually deployed with portable, point-of-care techniques. This approach features confocal microscopy. The investigators will compare this new approach with the gold standard of histology from a traditional skin punch biopsy (which is standard of care) to determine the sensitivity and specificity of portable confocal microscopy in diagnosing KS.

Conditions

  • Kaposi Sarcoma

Interventions

DEVICE

Smartphone confocal microscopy

Imaging of skin lesion using the smartphone confocal microscopy

Sponsors & Collaborators

  • National Institutes of Health (NIH)

    collaborator NIH

  • Infectious Diseases Institute, Uganda

    collaborator OTHER

  • Massachusetts General Hospital

    lead OTHER

Principal Investigators

  • Dongkyun Kang, PhD · Massachusetts General Hospital

Study Design

Allocation
NA
Purpose
DIAGNOSTIC
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-03-10
Primary Completion
2020-02-28
Completion
2020-02-28

Countries

  • Uganda

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03050788 on ClinicalTrials.gov